Abbott Named Industry Sustainability Leader for the Eighth Year in a Row on the Dow Jones Sustainability Index

- For the eighth consecutive year, Abbott (NYSE: ABT) has been named the industry leader in sustainability by the Dow Jones Sustainability Index (DJSI), one of the most prestigious global benchmarks for corporate sustainability. As the Global Industry Leader in the Health Care Equipment & Supplies sector, the company earned top scores for governanceeconomic and social performance. This is the 16 th consecutive year that Abbott has been recognized as a sustainability leader through its inclusion on the DJSI, including both the Dow Jones Sustainability World Index and North America Index.

"Sustainability in health care is about designing accessibility and affordability into the life-changing health technologies and products we create to help more people live healthier, fuller lives," said Robert B. Ford , president and chief executive officer, Abbott. "Abbott people have risen to that challenge this year, producing seven tests to help fight COVID-19 while continuing to advance new innovations in critical areas like diabetes, heart disease and nutrition, ultimately reaching nearly 2 billion people."

Abbott's overall score of 86 was more than triple the average score of 28 for other companies in its industry sector. Abbott achieved the top industry score in 11 of DJSI's 25 specific governance/economic, social and environmental criteria, including strategy to improve access to drugs or products, health outcome contribution, social reporting, human capital development, risk & crisis management, information security/cybersecurity & systems availability, customer relationship management, marketing practices, environmental reporting, operational eco-efficiency and occupational health and safety.

In addition to being included on DJSI, Abbott was named the 2020 World-Changing Company of the Year by Fast Company and was highlighted on Fortune's Change the World list. Abbott was also ranked No. 1 for social responsibility in its industry sector on Fortune's Most Admired Companies list for seven consecutive years (2014-2020), and was named one of the 100 Best Corporate Citizens by 3BL Media for 12 consecutive years (2009-2020).

Abbott's continued recognition demonstrates our longstanding commitment to sustainable, responsible business. Looking ahead, Abbott will further extend this commitment with the launch of its 2030 sustainability plan later this year. With forward-looking targets closely aligned to Abbott's purpose of helping people live fuller lives through better health, our 2030 plan will build a stronger, more sustainable Abbott that better serves the many people who depend on us.

To learn more about Abbott's strategic approach to sustainability, please visit abbott.com/sustainability .

For additional information on DJSI, please see the news release and DJSI Corporate Sustainability Assessment site.

About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 107,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com , on LinkedIn at www.linkedin.com/company/abbott-/ , on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews.

Cision View original content: https://www.prnewswire.com/news-releases/abbott-named-industry-sustainability-leader-for-the-eighth-year-in-a-row-on-the-dow-jones-sustainability-index-djsi-301173727.html

SOURCE Abbott

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
Seegnal (TSXV:SEGN)

Seegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm Summit

Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Corporation"), a global leader in AI-enhanced prescription intelligence, today announced real-world clinical results demonstrating how medication governance may reduce fall-risk drivers in older adults -- a significant clinical and financial challenge... Keep Reading...
Cardiologist wearing virtual reality glasses.

Top 3 Medical Device ETFs for Investors in 2026

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or... Keep Reading...
Stethoscope connected to a phone with medical data overlay.

Top 3 Small-cap Medical Device Stocks (Updated January 2026)

The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device technology. In 2024 alone, 30 new devices were approved by the US Food and Drug Administration (FDA).Wearable medical devices and the use of artificial intelligence in medical... Keep Reading...
Scientists working in a modern medical research laboratory.

Pathways to Commercialising Biotech Innovations

In the medical technology industry, innovation is only the first step. While key to long-term success, innovation is only as good as a company’s commercialisation strategy. Once a technology has been developed and proven, the organisation must then embark on a process to commercialise it for... Keep Reading...
Medical devices on a desk.

How to Invest in Medical Device Stocks and ETFs

The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare.This industry covers a wide range of health and medical instruments and equipment used in the treatment, mitigation, diagnosis and... Keep Reading...
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians. BlinkLab states in its Wednesday (March 12) release that the study is the largest digital... Keep Reading...

Interactive Chart

Latest Press Releases

Related News